Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Utah Medical Products (UTMD) Income from Continuing Operations (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Income from Continuing Operations data on record, last reported at 2631000.0 in Q3 2025.

  • For Q3 2025, Income from Continuing Operations fell 26.16% year-over-year to 2631000.0; the TTM value through Sep 2025 reached 24810000.0, up 615.81%, while the annual FY2024 figure was 13874000.0, 13.36% down from the prior year.
  • Income from Continuing Operations reached 2631000.0 in Q3 2025 per UTMD's latest filing, down from 3048000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 16090000.0 in Q4 2024 and bottomed at 7920000.0 in Q4 2022.
  • Average Income from Continuing Operations over 5 years is 3126842.11, with a median of 3563000.0 recorded in 2024.
  • Peak YoY movement for Income from Continuing Operations: plummeted 291.67% in 2022, then soared 314.39% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 4132000.0 in 2021, then tumbled by 291.67% to 7920000.0 in 2022, then rose by 5.24% to 7505000.0 in 2023, then skyrocketed by 314.39% to 16090000.0 in 2024, then tumbled by 83.65% to 2631000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Income from Continuing Operations were 2631000.0 in Q3 2025, 3048000.0 in Q2 2025, and 3041000.0 in Q1 2025.